Products in Development
| LifeForce currently
has three drug candidates in clinical trials. Amyloxine ® is being
developed for the potential treatment of Carcinoma (Cancer). Rotan®
is being developed for the potential treatment of Arthritus. A third product, MD-Amylox® is being developed for the
potential treatment of ARMD Macular Degeneration (Dry Type). CA-Amyline®
is being developed for the potential treatment of Coronary Artery Disease.. |
Clinical trials being conducted
by LifeForce Hospitals Research
| Amyloxine® |
Rotan® | MD-Amylox®
| | CA-Amyline® |Disclosure